Profile data is unavailable for this security.
About the company
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
- Revenue in CHF (TTM)49.74bn
- Net income in CHF21.66bn
- LocationNovartis AGLichtstrasse 35BASEL 4056SwitzerlandCHE
- Phone+41 613241111
- Fax+41 613247826
Mergers & acquisitions
|Acquired company||Deal status||Date||Date /|
|NOVN:SWX since |
|Gyroscope Therapeutics Holdings PLC(WAS 4L1215)||Deal completed||22 Dec 2021||22 Dec 2021Deal completed||2.12%||1.50bn|
|Alnylam Pharmaceuticals Inc||Rumoured||18 Nov 2021||18 Nov 2021Rumoured||6.32%||--|
|Arctos Medical AG||Deal completed||21 Sep 2021||21 Sep 2021Deal completed||4.96%||--|